592 related articles for article (PubMed ID: 35913831)
1. Differences in Surgical Outcomes and Quality-of-Life Outcomes in Pelvic Exenteration Between Locally Advanced Versus Locally Recurrent Rectal Cancers.
Huang Y; Steffens D; Koh CE; Young JM; Solomon MJ
Dis Colon Rectum; 2022 Dec; 65(12):1475-1482. PubMed ID: 35913831
[TBL] [Abstract][Full Text] [Related]
2. Outcomes Following Pelvic Exenteration for Locally Recurrent Rectal Cancer With and Without En Bloc Sacrectomy.
Waller JH; van Kessel CS; Solomon MJ; Lee PJ; Austin KKS; Steffens D
Dis Colon Rectum; 2024 Jun; 67(6):796-804. PubMed ID: 38408876
[TBL] [Abstract][Full Text] [Related]
3. Grading Complications in Pelvic Exenteration: Limitations of Current Classification Systems.
Huang Y; Wang X; Steffens D; Young J; Solomon M; Koh C
Dis Colon Rectum; 2023 Oct; 66(10):e1023-e1031. PubMed ID: 35067502
[TBL] [Abstract][Full Text] [Related]
4. Excellent Outcomes After Extended Radical Pelvic Resection for Locally Advanced and Recurrent IBD-Associated Anorectal Cancer.
Chang KH; Brown KGM; Chen Lau Y; Solomon MJ
Dis Colon Rectum; 2021 Feb; 64(2):209-216. PubMed ID: 33315717
[TBL] [Abstract][Full Text] [Related]
5. Omentoplasty in Patients Undergoing Abdominoperineal Resection After Long-Course Chemoradiation for Locally Advanced and Locally Recurrent Rectal Cancer: A Comparative Single-Institution Cohort Study.
van Campenhout I; van Rees JM; Ceelen W; Tanis PJ; Rothbarth J; Verhoef C
Dis Colon Rectum; 2023 Jul; 66(7):994-1002. PubMed ID: 36574322
[TBL] [Abstract][Full Text] [Related]
6. Clinical Significance of Preoperative and Postoperative Serum CEA and Carbohydrate Antigen 19-9 Levels in Patients Undergoing Curative Resection of Locally Recurrent Rectal Cancer.
Paku M; Uemura M; Kitakaze M; Miyoshi N; Takahashi H; Mizushima T; Doki Y; Eguchi H
Dis Colon Rectum; 2023 Mar; 66(3):392-400. PubMed ID: 36649161
[TBL] [Abstract][Full Text] [Related]
7. Laparoscopic Versus Open Surgery for Locally Advanced Rectal Cancer: Five-Year Survival Outcomes in a Large, Multicenter, Propensity Score-Matched Cohort Study.
Nishizaki D; Hida K; Sumii A; Okamura R; Sakai Y; Konishi T; Akiyoshi T; Maruyama S; Okajima M; Miyakura Y; Yamamoto S; Morita S; Watanabe M;
Dis Colon Rectum; 2022 Aug; 65(8):1005-1014. PubMed ID: 34775411
[TBL] [Abstract][Full Text] [Related]
8. Impact of Total Neoadjuvant Therapy on Postoperative Outcomes After Proctectomy for Rectal Cancer.
Xu Z; Valente MA; Sklow B; Liska D; Gorgun E; Kessler H; Rosen DR; Steele SR
Dis Colon Rectum; 2023 Jul; 66(7):1022-1028. PubMed ID: 36538720
[TBL] [Abstract][Full Text] [Related]
9. Short-Course Radiotherapy Followed by Consolidation Chemotherapy Is Safe and Effective in Locally Advanced Rectal Cancer: Comparative Short-term Results of Multicenter Propensity Score Case-Matched Study.
Benlice C; Koc MA; Gulcu B; Bilgin IA; Akyol C; Baca B; Ozturk E; Guney Y; Utkan G; Er O; Agaoglu F; Yildirim I; Avci N; Elhan AH; Kuzu MA
Dis Colon Rectum; 2023 May; 66(5):681-690. PubMed ID: 36856669
[TBL] [Abstract][Full Text] [Related]
10. Pelvic Exenteration for Squamous Cell Carcinoma of the Anus: Oncological, Morbidity, and Quality-of-Life Outcomes.
Brown KGM; Solomon MJ; Steffens D; Ng KS; Byrne CM; Austin KKS; Lee PJ
Dis Colon Rectum; 2023 Nov; 66(11):1427-1434. PubMed ID: 37493254
[TBL] [Abstract][Full Text] [Related]
11. Rectal Cancer: Clinical and Molecular Predictors of a Complete Response to Total Neoadjuvant Therapy.
Chapman BC; Lai SH; Friedrich T; Lieu CH; Moskalenko M; Olsen JR; Herter W; Birnbaum EH; McCarter MD; Vogel JD
Dis Colon Rectum; 2023 Apr; 66(4):521-530. PubMed ID: 34984995
[TBL] [Abstract][Full Text] [Related]
12. Re-resection of Microscopically Positive Margins Found on Intraoperative Frozen Section Analysis Does Not Result in a Survival Benefit in Patients Undergoing Surgery and Intraoperative Radiation Therapy for Locally Recurrent Rectal Cancer.
Ansell J; Perry WRG; Mathis KL; Grass F; Yonkus JA; Hallemeier CL; Haddock MG; Graham RP; Merchea A; Colibaseanu DT; Mishra N; Kelley SR; Larson DW; Dozois EJ
Dis Colon Rectum; 2022 Sep; 65(9):1094-1102. PubMed ID: 35714345
[TBL] [Abstract][Full Text] [Related]
13. Does Sarcopenia Predict Local Response Rates After Chemoradiotherapy for Locally Advanced Rectal Cancer?
Bedrikovetski S; Traeger L; Vather R; Sammour T; Moore JW
Dis Colon Rectum; 2023 Jul; 66(7):965-972. PubMed ID: 36538702
[TBL] [Abstract][Full Text] [Related]
14. Downstaging in Advanced Rectal Cancers: A Propensity-Matched Comparison Between Short-Course Radiotherapy Followed by Chemotherapy and Long-Course Chemoradiotherapy.
Kammar PS; Garach NR; Masillamany S; de'Souza A; Ostwal V; Saklani AP
Dis Colon Rectum; 2022 Oct; 65(10):1215-1223. PubMed ID: 34907988
[TBL] [Abstract][Full Text] [Related]
15. Delayed TME Surgery in a Watch-and-Wait Strategy After Neoadjuvant Chemoradiotherapy for Rectal Cancer: An Analysis of Hospital Costs and Surgical and Oncological Outcomes.
Meyer VM; Meuzelaar RR; Schoenaker IJH; de Groot JB; Reerink O; de Vos Tot Nederveen Cappel WH; Beets GL; van Westreenen HL
Dis Colon Rectum; 2023 May; 66(5):671-680. PubMed ID: 34856587
[TBL] [Abstract][Full Text] [Related]
16. Total Neoadjuvant Therapy With Short-Course Radiation: US Experience of a Neoadjuvant Rectal Cancer Therapy.
Chapman WC; Kim H; Bauer P; Makhdoom BA; Trikalinos NA; Pedersen KS; Glasgow SC; Mutch MG; Silviera ML; Roy A; Parikh PJ; Hunt SR
Dis Colon Rectum; 2022 Feb; 65(2):198-206. PubMed ID: 34990423
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of Patients With Local Regrowth After Nonoperative Management of Rectal Cancer After Neoadjuvant Chemoradiotherapy.
Cotti GC; Pandini RV; Braghiroli OFM; Nahas CSR; Bustamante-Lopez LA; Marques CFS; Imperiale AR; Ribeiro U; Salvajoli B; Hoff PM; Nahas SC
Dis Colon Rectum; 2022 Mar; 65(3):333-339. PubMed ID: 34775415
[TBL] [Abstract][Full Text] [Related]
18. Quality of Life and Functional Outcomes After Intersphincteric Resection for Ultralow Rectal Cancer: A Prospective Observational Study.
Zhang B; Zhuo GZ; Zhao Y; Zhao YJ; Zhu J; Liu FF; Ding JH
Dis Colon Rectum; 2023 Jul; 66(7):1029-1038. PubMed ID: 36602458
[TBL] [Abstract][Full Text] [Related]
19. Total Neoadjuvant Therapy Significantly Increases Complete Clinical Response.
Rettig RL; Beard BW; Ryoo JJ; Kulkarni S; Gulati M; Tam M; Attaluri V
Dis Colon Rectum; 2023 Mar; 66(3):374-382. PubMed ID: 35239525
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Impact of Lymphatic Invasion, Venous Invasion, Perineural Invasion, and Tumor Budding in Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy Followed by Total Mesorectal Excision.
Kim S; Huh JW; Lee WY; Yun SH; Kim HC; Cho YB; Park YA; Shin JK
Dis Colon Rectum; 2023 Jul; 66(7):905-913. PubMed ID: 35195558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
